Buscar
-
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection
(The Journal of Antimicrobial Chemotherapy. vol. 76, n° 2, pp. 482-486, 2021-01-19)Article de revue -
COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers’ Poor Mental Health
(Journal of Alzheimer's disease. pp. 1-9, 2021-02-23)Article de revue -
Anticholinergic Activity of Psychotropic Drugs and Cognitive Impairment Among Participants Aged 45 and Over: The CONSTANCES Study
(Drug Safety, 2021-02-11)Article de revue -
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure
(Graefe's Archive for Clinical and Experimental Ophthalmology. vol. 259, pp. 567–574, 2021-02-02)Article de revueLibre acceso -
Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence
(The British Journal of Ophthalmology. vol. 105, n° 11, 2021-10-21)Article de revueLibre acceso -
Efficacy and Safety of Intravitreal Aflibercept Treat-and-Extend for Macular Edema in Central Retinal Vein Occlusion: The CENTERA Study
(American Journal of Ophthalmology, 2021-02-06)Article de revueLibre acceso -
Cognitive and Motor Skills of People with Down Syndrome According to Their Perceived Self-Determination
(Journal of Developmental and Physical Disabilities, 2021-03-22)Article de revue -
Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis
(Neurology, 2021-02-10)Article de revue -
Treatment resistant depression incidence and prevalence using the French nationwide claims database
(Pharmacoepidemiology and Drug Safety. vol. 30, n° 2, pp. 169–177, 2021-02)Article de revue -
Decongestant use and the risk of myocardial infarction and stroke: a case-crossover study
(Scientific Reports. vol. 11, n° 1, pp. 4160, 2021-02-18)Article de revueLibre acceso